Hydropothecary to build $80mn cannabis facility

By zaymalz malz
Share

Hydropothecary, a leading Canadian marijuana Corporation, has acquired 78 acres of land adjacent to its existing facility in Gatineau, Quebec, that will be used to construct a new 1mn sq ft production greenhouse.

The new facility, expected to cost $80mn, will expand Hydropothecary’s Gatineau plant to a total 1.3mn sq ft, increasing its production capacity to a total 108,000kg of dried cannabis annually.

See also:

"Hydropothecary is boldly stepping forward to take the lead in the Canadian cannabis industry,” said Sebastian St. Louis, CEO and Co-Founder of the Hydropothecary Corporation. “With our expansion, we are moving into industrial agri-nomics, robotic technology, fully automated systems and the cannabis plant as a THC bioreactor.”

The work has been planned in anticipation of Quebec’s legalisation of Cannabis, with a number of firms including Aurora Cannabis and CanniMed making similar moves within the industry.

According to a recent report from Ernst & Young, over one third of Canadian cannabis companies are upping their capacity in anticipation of an increased post-legalisation demand.

“Once legalization of the adult-use recreational market becomes a reality, Hydropothecary will be ready,” St. Louis continued.

The expansion work is expected to be completed for December 2018.

Share

Featured Articles

Best US Cities To Grow Your Multinational Company

You’re ready to grow your business, expand to other regions and take on new clients. To compete with some of the biggest, most successful companies out the

Why Germany’s economy is sliding into recession - Bloomberg

Germany faces a flat 2024 having slipped into recession. Why is Germany at risk of becoming ‘the sick man of Europe’ and what does it mean for its CEOs?

UK Entrepreneurs Ratchet Up Selling Off Their Businesses

British business owners spooked by impending tax hikes accelerate plans to sell off their businesses, as executives of UK-listed companies dump shares

UK Employment Rights Bill - What It Means for Your Business

Human Capital

Q&A: Former Novartis CEO Daniel Vasella - McKinsey

Leadership & Strategy

Share of Population Who are Millionaires to Drop by 20%

Corporate Finance